Preferred
(EDT)

[Harnessing the Microbiome] Clinical Trials to Optimize Microbiome‑Mediated Disease Resistance

2:15 PM - 3:50 PM EST
Wednesday, January 20, 2021Room: V100 - Atticus
Other
Clinical Trials to Optimize Microbiome‑Mediated Disease Resistance
Microbiome Therapeutics to Treat Bacterial Infections and Inflammatory Disease
2:15 PM - 2:35 PM EST
Wednesday, January 20, 2021Room: V100 - Atticus
Speaker
Speaker Image
Matthew Henn, PhD
Seres Therapeutics
Clinical Trials to Optimize Microbiome‑Mediated Disease Resistance
[NOT AVAILABLE ON DEMAND] Medicines Based on Defined Bacterial Consortia
2:35 PM - 2:55 PM EST
Wednesday, January 20, 2021
Speaker
Speaker Image
Bernat Olle, PhD
Vedanta Biosciences
Clinical Trials to Optimize Microbiome‑Mediated Disease Resistance
Synthetic Glycans to Optimize Microbiome Composition and Function
2:55 PM - 3:15 PM EST
Wednesday, January 20, 2021Room: V100 - Atticus
Speaker
Speaker Image
Johan van Hylckama Vlieg, PhD
Kaleido Biosciences
Clinical Trials to Optimize Microbiome‑Mediated Disease Resistance
Short Talk: Development of a Synthetic Biotic for the Treatment of Enteric Hyperoxaluria
3:15 PM - 3:35 PM EST
Wednesday, January 20, 2021Room: V100 - Atticus
Speaker
Speaker Image
Mark Charbonneau, PhD
Synlogic
Clinical Trials to Optimize Microbiome‑Mediated Disease Resistance
Panel Q&A
3:35 PM - 3:50 PM EST
Wednesday, January 20, 2021
Clinical Trials to Optimize Microbiome‑Mediated Disease Resistance


Copyright © 2025 Keystone Symposia
Powered by Conexiant DXP
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.